1-3 of 3
Nina K. Steckel, M.D.
Close
Sort by
Journal Articles

Reduced Incidence of Severe Acute GVHD in Patients Transplanted from Donors with IL23R (Arg381Gln) Gene Variant.

Ahmet H. Elmaagacli, MD, Michael Koldehoff, M.D., Nina K. Steckel, M.D., Dietrich Beelen, M.D.
Journal: Blood
Blood (2007) 110 (11): 1061.
https://doi.org/10.1182/blood.V110.11.1061.1061
Published: 2007
Journal Articles

Adoptive Donor T-Cell Infusions Are Necessary and Efficient To Induce Lasting Molecular Remissions after Highly Purified CD34+ Sibling Donor Transplants for First Chronic Phase Chronic Myeloid Leukemia - Final Report and Long-Term Follow-Up of a Phase II Study.

Ahmet Elmaagacli, MD, Rudolf Peceny, M.D., Michael Koldehoff, M.D., Hellmut Ottinger, M.D., Rudolf Trenschel, M.D., Nina K. Steckel, M.D., Dietrich W. Beelen, M.D.
Journal: Blood
Blood (2006) 108 (11): 3017.
https://doi.org/10.1182/blood.V108.11.3017.3017
Published: 2006
Journal Articles

Mutations Innate Immune System NOD/CARD15 Gene and Toll-Like-Receptor-4 Gene Are Associated with Increased Risk for Severe Acute Gvhd in Patients Who Underwent Allogeneic Transplantation.

Ahmet H. Elmaagacli, M.D., Michael Koldehoff, M.D., Nina K. Steckel, M.D., Heidrun Hindahl, M.D., Rudolf Trenschel, M.D., Hellmut Ottinger, M.D., Dietrich W. Beelen, M.D.
Journal: Blood
Blood (2004) 104 (11): 425.
https://doi.org/10.1182/blood.V104.11.425.425
Published: 2004